Hainan Shuangcheng Pharmaceut (002693) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of Hainan Shuangcheng Pharmaceut stock ¥0.71, price ¥6.95, that is 89.8% below the price, quality 66 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Hainan Shuangcheng Pharmaceut
002693 · SHEFar too expensive (fair value 90% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 21, 2026.
How to read this chart
60‑month range ¥3.75 – ¥38.37 · fair‑value band ¥0.44 – ¥1.03 · the ¥6.95 price screens above the ¥0.71 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 21, 2026.
Every Wednesday you see whether Hainan Shuangcheng Pharmaceut is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in research and development, production, and sale of pharmaceutical injections, solid preparations, and raw materials in China and internationally.
Show moreShow less
The company offers products for oncology and immune, alimentary canal, heart and cerebral, and vessels and metabolism.
It also provides Bivalirudin, Epitifibatide, and Thymalfaxin for injection; Pregabalin capsule; and Memantine Hydrochloride tablets and Pioglitazone tablets USP. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and is headquartered in Haikou, the People's Republic of China.
Stock analysis
Hainan Shuangcheng Pharmaceut (002693) currently trades at ¥6.95, while our model-based Fair Value estimate is ¥0.71, 90% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ¥0.895 per share, and 0 of the 26 models we run sit above the ¥6.95 price.
Bear case: the Dividend Discount group reads lowest at ¥0.155, and 26 of the 26 models stay below the price. Data coverage for this calculation is low.
Scenario range: ¥0.44 (bear) to ¥1.03 (bull), the price of ¥6.95 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 66/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Hainan Shuangcheng Pharmaceut reported revenue of 277M CNY in FY2025 versus 320M CNY in FY2021, a compound −3.6%/yr. Reported net income was 19.0M CNY in FY2025.
Key figures
Market cap 2.9B CNY (≈ $432M) Small · P/E ratio 63.2 · P/S ratio 8.85 · EPS (TTM) ¥0.11 · Dividend yield 0.2% · Net margin 14.7% · Return on equity 8.1% · Return on assets (EBIT) −5.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 40% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −26% fair-value upside, at −90%, 002693 screens richer than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
002693 screens overvalued: fair value 90% below the price. Compare with Merck KGaA →
Compare Hainan Shuangcheng Pharmaceut with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 610 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/S ratio by industry
- EBIT margin by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Chinese Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $79.11 | $113.53 | +44% | vs 002693 |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.00 | ¥52.43 | +12% | vs 002693 |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,884.90 | ₹1,982.92 | +5% | vs 002693 |
| Haleon plc HLN | $9.07 | $8.47 | −7% | vs 002693 |
| Merck KGaA MRK | €146.45 | €108.83 | −26% | vs 002693 |
| Galderma Group GALD | CHF 182.85 | CHF 112.84 | −38% | vs 002693 |
| Teva Pharmaceutical Industries Limited TEVA | $39.23 | $20.74 | −47% | vs 002693 |
| Takeda Pharmaceutical Company TAK | $21.77 | $11.26 | −48% | vs 002693 |
| Sandoz Group SDZ | CHF 80.50 | CHF 41.06 | −49% | vs 002693 |
| Divi's Laboratories Limited DIVISLAB | ₹11,180.50 | ₹1,566.89 | −86% | vs 002693 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Hainan Shuangcheng Pharmaceut (002693) overvalued or undervalued?
What is the fair value of 002693?
What is the quality score of 002693?
What is the price target for Hainan Shuangcheng Pharmaceut (002693)?
What is the Hainan Shuangcheng Pharmaceut stock forecast for 2026?
What is the revenue of Hainan Shuangcheng Pharmaceut (002693)?
Does Hainan Shuangcheng Pharmaceut pay a dividend?
How much is the dividend of Hainan Shuangcheng Pharmaceut (002693)?
What growth is priced into Hainan Shuangcheng Pharmaceut (002693)?
What discount rate (WACC) does the fair value of 002693 use?
What is a reverse DCF?
How much growth has Hainan Shuangcheng Pharmaceut (002693) delivered so far?
How fast is the sector of Hainan Shuangcheng Pharmaceut (002693) growing?
What is the free cash flow yield of Hainan Shuangcheng Pharmaceut (002693)?
What is the intrinsic value of Hainan Shuangcheng Pharmaceut (002693)?
Is Hainan Shuangcheng Pharmaceut stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 002693?
How much is Hainan Shuangcheng Pharmaceut worth?
What do the bullish and bearish scenarios say about 002693?
What is the P/E ratio of 002693?
How solid is the balance sheet of Hainan Shuangcheng Pharmaceut (002693)?
How far is 002693 from its 52-week high?
Which stocks are comparable to Hainan Shuangcheng Pharmaceut?
Is Hainan Shuangcheng Pharmaceut stock attractive at the current price?
How is the fair value of 002693 calculated?
Is it still worth investing in stocks now?
What is the share price of Hainan Shuangcheng Pharmaceut (002693)?
What should I pay attention to with Hainan Shuangcheng Pharmaceut right now?
Key figures of Hainan Shuangcheng Pharmaceut
How large is the market capitalisation of Hainan Shuangcheng Pharmaceut (002693)?
What is the P/S ratio of Hainan Shuangcheng Pharmaceut (002693)?
What are the earnings per share of Hainan Shuangcheng Pharmaceut (002693)?
What is the dividend yield of Hainan Shuangcheng Pharmaceut (002693)?
What is the net margin of Hainan Shuangcheng Pharmaceut (002693)?
What is the return on equity of Hainan Shuangcheng Pharmaceut (002693)?
What is the EBIT return on assets of Hainan Shuangcheng Pharmaceut (002693)?
What is the operating margin of Hainan Shuangcheng Pharmaceut (002693)?
How fast is revenue growing at Hainan Shuangcheng Pharmaceut (002693)?
How fast are earnings growing at Hainan Shuangcheng Pharmaceut (002693)?
How much net debt does Hainan Shuangcheng Pharmaceut (002693) carry?
Watch Hainan Shuangcheng Pharmaceut in the live analysis
One click puts Hainan Shuangcheng Pharmaceut on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.